Lenalidomide in multiple myeloma
Author:
Publisher
Elsevier BV
Subject
Clinical Biochemistry,Oncology
Reference86 articles.
1. VAD-based regimens as primary treatment for multiple myeloma;Alexanian;American Journal of Hematology,1990
2. Melphalan therapy for plasma cell myeloma;Alexanian;Blood,1968
3. Primary dexamethasone treatment of multiple myeloma;Alexanian;Blood,1992
4. Treatment for multiple myeloma. Combination chemotherapy with different melphalan dose regimens;Alexanian;The Journal of the American Medical Association,1969
5. Impact of complete remission with intensive therapy in patients with responsive multiple myeloma;Alexanian;Bone Marrow Transplantation,2001
Cited by 13 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. The emerging therapeutic landscape of relapsed/refractory multiple myeloma;Annals of Hematology;2022-12-03
2. The role of phosphoric acid in the crystallization of lenalidomide form DH–water system;CrystEngComm;2022
3. Solubility and thermodynamic properties of hydrate lenalidomide in phosphoric acid solution;Journal of Molecular Liquids;2021-05
4. A PROSPECTIVE COMPARATIVE STUDY OF SAFETY OF LENALIDOMIDE PLUS DEXAMETHASONE COMBINATION THERAPY VERSUS VAD (VINCRISTINE, DOXORUBICIN AND DEXAMETHASONE) REGIMEN IN THE TREATMENT OF MULTIPLE MYELOMA;International Journal of Pharmaceutical Sciences and Research;2017-11-01
5. Immunomodulatory Agents and Proteasome Inhibitors in the Treatment of Multiple Myeloma;Seminars in Oncology Nursing;2017-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3